Final results of a long-term, clinical follow-up in fatty liver patients

References

• Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356–9
   PubMed Web of Science ®Google Scholar
• Andersen T, Gluud C. Liver morphology in morbid obesity: a literature study. Int J Obes 1984; 8: 97–106
   PubMed Web of Science ®Google Scholar
• Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001; 121: 91–100
   PubMed Web of Science ®Google Scholar
• Dixon JB, Bhathal PS, Hughes NR, O'Brien PE. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology 2004; 39: 1647–54
   PubMed Web of Science ®Google Scholar
• Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999; 107: 450–5
   PubMed Web of Science ®Google Scholar
• Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 35: 373–9
   PubMed Web of Science ®Google Scholar
• Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917–23
   PubMed Web of Science ®Google Scholar
• Diehl AM, Goodman Z, Ishak KG. Alcohol-like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988; 95: 1056–62
   PubMed Web of Science ®Google Scholar
• Lee RG. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol 1989; 20: 594–8
   PubMed Web of Science ®Google Scholar
• Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995; 22: 1714–9
   PubMed Web of Science ®Google Scholar
• Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990; 11: 74–80
   PubMed Web of Science ®Google Scholar
• Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity [see comments]. Gastroenterology 1994; 107: 1103–9
   PubMed Web of Science ®Google Scholar
• Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006; 44: 865–73
   PubMed Web of Science ®Google Scholar
• Kozararevic D, McGee D, Vojvodic N, Racic Z, Dawber T, Gordon T, et al. Frequency of alcohol consumption and morbidity and mortality: the Yugoslavia Cardiovascular Disease Study. Lancet 1980; 1: 613–6
   PubMed Web of Science ®Google Scholar
• Shaper AG, Wannamethee G, Walker M. Alcohol and mortality in British men: explaining the U-shaped curve. Lancet 1988; 2: 1267–3
   PubMed Web of Science ®Google Scholar
• Klatsky AL, Armstrong MA, Friedman GD. Alcohol and mortality. Ann Intern Med 1992; 117: 646–54
   PubMed Web of Science ®Google Scholar
• Gronbaek M, Deis A, Sorensen TI, Becker U, Borch-Johnsen K, Muller C, et al. Influence of sex, age, body mass index, and smoking on alcohol intake and mortality. Br Med J 1994; 308: 302–6
   PubMed Web of Science ®Google Scholar
• Itoh S, Yougel T, Kawagoe K. Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis. Am J Gastroenterol 1987; 82: 650–4
   PubMed Web of Science ®Google Scholar
• Burt AD, Mutton A, Day CP. Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol 1998; 15: 246–58
   PubMed Web of Science ®Google Scholar
• Sleisenger & Fordtran's Gastrointestinal and liver disease, 7th ed. Philadelphia: WB Saunders; 2002.
   Google Scholar
• Dam-Larsen S, Franzmann M, Andersen IB, Christoffersen P, Jensen LB, Sørensen TI, et al. Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut 2004; 53: 750–5
   PubMed Web of Science ®Google Scholar
• Dam-Larsen S, Franzmann MB, Christoffersen P, Larsen K, Becker U, Bendtsen F. Histological characteristics and prognosis in patients with fatty liver. Scand J Gastroenterol 2005; 40: 460–7
   PubMed Web of Science ®Google Scholar
• Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46: 263–8
   PubMed Web of Science ®Google Scholar
• Juel K, Helweg-Larsen K. The Danish registers of causes of death. Dan Med Bull 1999; 46: 354–7
   PubMed Web of Science ®Google Scholar
• Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions [see comments]. Am J Gastroenterol 1999; 94: 2467–74
   PubMed Web of Science ®Google Scholar
• Hayashi PH, Harrison SA, Torgerson S, Perez TA, Nochajski T, Russell M. Cognitive lifetime drinking history in nonalcoholic fatty liver disease: some cases may be alcohol related. Am J Gastroenterol 2004; 99: 76–81
   PubMed Web of Science ®Google Scholar
• Becker U, Deis A, Sorensen TIA, Gronbaek M, Borch-Johnsen K, Muller CF, et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 1996; 23: 1025–9
   PubMed Web of Science ®Google Scholar
• Day CP. Alcoholic liver disease: dose and threshold: new thoughts on an old topic. Gut 1997; 41: 857–8
   PubMed Web of Science ®Google Scholar
• Kamper-Jorgensen M, Gronbaek M, Tolstrup J, Becker U. Alcohol and cirrhosis: dose–response or threshold effect?. J Hepatol 2004; 41: 25–30
   PubMed Web of Science ®Google Scholar
• Sørensen TIA, Orholm M, Bentsen KD, Hoybye G, Eghoje K, Christoffersen P. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet 1984; 2: 241–4
   PubMed Web of Science ®Google Scholar
• Orholm M, Sorensen TIA, Bentsen K, Hoybye G, Eghoje K, Christoffersen P. Mortality of alcohol abusing men prospectively assessed in relation to history of abuse and degree of liver injury. Liver 1985; 5: 253–60
   PubMedGoogle Scholar
• Chedid A, Mendenhall CL, Gartside P, French SW, Chen T, Rabin L. Prognostic factors in alcoholic liver disease. VA Cooperative Study Group. Am J Gastroenterol 1991; 86: 210–6
   PubMed Web of Science ®Google Scholar
• Bouchier IA, Hislop WS, Prescott RJ. A prospective study of alcoholic liver disease and mortality. J Hepatol 1992; 16: 290–7
   PubMed Web of Science ®Google Scholar
• Teli MR, Day CP, Burt AD, Bennett MK, James OF. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver [see comments]. Lancet 1995; 346: 987–90
   PubMed Web of Science ®Google Scholar
• Becker U, Gronbaek M, Johansen D, Sorensen TI. Lower risk for alcohol-induced cirrhosis in wine drinkers. Hepatology 2002; 35: 868–75
   PubMed Web of Science ®Google Scholar
• Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413–9
   PubMed Web of Science ®Google Scholar
• Bedogni G, Miglioli L, Masutti F, Castiglione A, Croce LS, Tiribelli C, et al. Incidence and natural course of fatty liver in the general population: the Dionysos study. Hepatology 2007; 46: 1387–91
   PubMed Web of Science ®Google Scholar
• Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol 2008; 49: 608–612
   PubMed Web of Science ®Google Scholar
• Day CP, James OF. Steatohepatitis: a tale of two “hits”? [editorial]. Gastroenterology 1998; 114: 842–5
   PubMed Web of Science ®Google Scholar
• Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003; 37: 1286–92
   PubMed Web of Science ®Google Scholar